News & Events

Investor Relations R

Lipidor AB (publ) publishes interim report for third quarter 2022

STOCKHOLM, Sweden, 23 November 2022 – Today, Lipidor AB (publ)… Read More

Investor Relations

Lipidor provides update following outcome of Phase III study of psoriasis candidate AKP02

STOCKHOLM, 15 November 2022 – On October 28, Lipidor AB… Read More

Investor Relations R

Lipidor announces results from the company’s clinical Phase III study of AKP02 for psoriasis

STOCKHOLM 28 October 2022 – Lipidor AB (publ) (Nasdaq First… Read More


Biotech Show Case Conference. San Francisco, USA

We will be present during the BIOTECH SHOWCASE conference… Read More


CPHI Worldwide. Frankfurt, Germany

We will be present during CPhI Worldwide in Frankfurt,… Read More



The Lipidor team will be in Japan, 21-25 October… Read More